"","Num","POD","SD","%","Genes","KE"
"INCREASED LEVEL OF HIPPURIC ACID IN URINE","2","2.95199601583942","1.12649101273207","66.67","bckdha, pccb","INCREASED BLOOD URIC ACID CONCENTRATION"
"GO:1904019","4","3.03875164619919","0.547828141638459","18.18","cd40, hmox1a, rb1, tek","DECREASE APOPTOSIS OF CILIATED EPITHELIAL CELLS"
"LIPID METABOLISM PATHWAY","2","3.23276792834356","1.15439257084853","16.67","bckdha, fasn","DAMAGE LIPID BILAYER"
"GO:0043542","5","6.31077035903406","0.406115471719338","14.29","acvrl1, cd40, hmox1a, id1, tek","INCREASED MIGRATION ENDOTHELIAL CELLS"
"SOMATIC MUTATION","4","12.1728138561647","0.525386986475857","4.76","pax6b, ptpn11a, rad54l, rb1","INCREASED INDUCED MUTATIONS IN CRITICAL GENES; INCREASE MUTATIONS; INCREASE MUTATIONS IN CRITICAL GENES"
"ABNORMALITY OF THE BLADDER","8","18.6736068204567","0.210650214012889","15.38","cdc45, chrm3a, hnrnpa1b, nfia, pax6b, rarga, smad3a, stub1","REDUCED POSTERIOR SWIM BLADDER INFLATION; REDUCED ANTERIOR SWIM BLADDER INFLATION; INCREASE URINARY BLADDER CALCULI"
"GO:0022414","6","18.7165368383522","0.277034965780693","16.67","ahr2, h2afx, igf1rb, mre11a, rad54l, rpa1","INCREASED REPRODUCTIVE SUCCESS"
"GO:0051899","3","19.6384424337089","0.294866254632795","14.29","chrna6, jun, kcnh2a","OCCURRENCE A PAROXYSMAL DEPOLARIZING SHIFT; PROLONGED DEPOLARIZATION OF NEURONAL MEMBRANE"
"NRF2 PATHWAY","4","19.9139330743737","0.173761072521742","10","hmox1a, hsp90aa1.2, rxraa, txn","ACTIVATION NRF2"
"GO:0006281","14","21.1956370202634","0.114628592828931","16.47","cdc45, chek1, ddb2, h2afx, hsf1, lig3, mcm4, mre11a, pola1, polr2j, rad54l, rpa1, rpa3, stub1","N/A INSUFFICIENT OR INCORRECT DNA REPAIR; INCREASED INSUFFICIENT REPAIR OR MIS-REPAIR OF PRO-MUTAGENIC DNA ADDUCTS; OVERWHELMED MITOCHONDRIAL DNA REPAIR MECHANISMS; INCREASED DNA DAMAGE-REPAIR"
"GLOMERULAR SCLEROSIS","2","21.5827139232925","0.653225594834532","14.29","ikbkap, nup133","DECREASED GLOMERULAR FILTRATION"
"ABNORMAL RENAL TUBULE MORPHOLOGY","2","22.1921376205073","0.661776695614553","22.22","nup133, pmm2","OCCURRENCE CYSTIC DILATATION RENAL TUBULE; OCCURRENCE CYTOPLASMIC VACUOLIZATION RENAL TUBULE"
"GO:0015464","2","23.797254522756","0.587432724608018","25","chrm3a, chrna6","ACTIVATION NICOTINIC ACETYLCHOLINE RECEPTOR"
"INHIBITION ACETYLCHOLINESTERASE ACHE","2","23.797254522756","0.587432724608018","18.18","chrm3a, chrna6","INHIBITION ACETYLCHOLINESTERASE ACHE"
"ABNORMAL CARDIAC TEST","2","24.5053435011722","0.230166959282192","15.38","kcnh2a, sox19b","INCREASED CARDIAC ARRTHYMIA"
"ABNORMAL BLOOD POTASSIUM CONCENTRATION","3","24.5519173760734","0.258792091893708","25","hsd11b2, hsd3b1, kcnh2a","INCREASED BLOOD POTASSIUM CONCENTRATION"
"GO:0001935","6","26.9061228521654","0.317287883209475","16.67","acvrl1, f3a, flt1, hmox1a, jun, tek","INCREASED PROLIFERATION ENDOTHELIAL CELLS"
"GO:0042701","4","28.2136688513673","0.169575066790237","11.76","hsp90aa1.1, hsp90aa1.2, igf1rb, mapk3","DECREASED PROGESTERONE FROM CORPUS LUTEUM"
"GO:0019904","26","30.5729674201645","0.0435666354843676","21.14","cd40, cdc42, chek1, dnm1l, esrra, esrrga, gria1b, hnrnpa1b, hoxb1a, hsp90aa1.2, jun, kcnh2a, lyn, ncoa2, pax6b, polr2j, pparab, ptpn11a, rb1, rnf2, rxraa, srsf10b, stub1, syk, ube2ia, ywhaz","N/A INTERFERENCES WITH SH-/SELEN-PROTEINS"
"GO:0006954","13","31.2536415755242","0.10560705794424","11.11","cd40, f3a, hmox1a, jun, lyn, pparab, rb1, rps6ka5, seh1l, sele, smad3a, syk, tek","INCREASE INFLAMMATION; INCREASE INFLAMMATION CORNEAL CELLS; INFILTRATION INFLAMMATORY CELLS; INCREASED INFLAMMATION; CHRONIC COUGH RESPIRATORY IRRITABILITY"
"GO:0019932","7","33.7558577145265","0.233065136816268","11.48","ahr1b, drd1b, drd2b, gsk3b, pde5ab, sele, syk","INCREASED SECOND MESSENGER PRODUCTION"
"ABNORMAL CIRCULATING RENIN","2","35.7478841058265","0.511317778322931","33.33","hsd11b2, hsd3b1","REDUCTION GONADOTROPINS CIRCULATING CONCENTRATIONS"
"GO:0007249","4","35.8746306770745","0.250173301396455","9.3","cd40, hmox1a, ube2ia, wls","INHIBITION NUCLEAR FACTOR KAPPA B NF-KB"
"CTOME FOXO MEDIATED TRANSCRIPTION","3","36.4179453955187","0.287405902782992","10.71","smad3a, txn, ywhaz","ACTIVATION FOXO"
"GLUCOCORTICOID RECEPTOR PATHWAY","3","36.5835673801692","0.212747805977767","12.5","hsp90aa1.2, jun, rxraa","ACTIVATION GLUCOCORTICOID RECEPTOR"
"GO:0001525","8","40.883913018101","0.206335277888494","21.62","flt1, gsk3b, hdac3, igfbp2a, rab5c, tek, vegfaa, wdr43","REDUCTION ANGIOGENESIS; INCREASED ANGIOGENESIS"
"GO:0015631","3","41.3510776566347","0.285271648923441","15.79","dnm1l, gli1, lyn","BINDING TUBULIN"
"GO:0006936","9","42.1159539988777","0.162218557707941","16.36","chrm3a, drd1b, drd2b, gamt, glra1, kcnh2a, myl6, pde5ab, tpm4a","REDUCTION ABDOMINAL MUSCLE CONTRACTION; OVERACTIVATION MUSCLE CONTRACTION"
"GO:0000003","31","47.4478277443898","0.0354218410261271","15.27","arntl1a, cad, dldh, drd1b, e2f7, eif2b4, gamt, gli1, glra1, h2afx, hsd11b2, hsd17b2, hsf1, igfbp2a, ldha, mapk3, mre11a, ndc1, P2RY1, pde5ab, ptpn11a, rad54l, rarga, rdh10a, rnf2, rpa1, rxraa, sirt2, tcf7, txn, umps","REDUCED REPRODUCTIVE SUCCESS; REPRODUCTIVE FAILURE"
"GO:0072358","18","47.6217454060998","0.0648170849194978","16.22","acvrl1, ahr1b, anxa2a, cd40, cdc42, dhcr7, e2f7, epha2a, f3a, flt1, hmox1a, id1, jun, pax6b, rras, smad1, syk, tek","ALTERED CARDIOVASCULAR DEVELOPMENT/FUNCTION"
"GO:0016310","13","47.7963927297792","0.101352702248717","10.4","acvrl1, chek1, csnk2a2a, epha2a, flt1, gsk3b, igf1rb, lyn, mapk3, rps6ka5, syk, tek, zgc-86598","ACTIVATION SP1"
"GO:0001775","20","47.8263072570959","0.0540055554003243","10.2","ahr1b, anxa2a, cd40, cdc42, hmox1a, hsp90aa1.2, igfbp2a, jun, lyn, mapk3, P2RY1, pde5ab, psmd6, ptpn11a, rab5c, rap1b, smad3a, syk, tcf7, ywhaz","ACTIVATION DENDRITIC CELLS"
"GO:0030154","12","49.4720248374549","0.0446422148082316","18.46","cpsf5, lyn, nkx2.7, nr2f5, pparab, rarga, rb1, rbl1, rxraa, rxrbb, sox19b, vegfaa","DIFFERENTIATION OF MYOFIBROBLAST"
"HEART DEVELOPMENT","14","49.9239901515314","0.0900278864926796","11.11","acvrl1, cad, cdc42, gli1, mapk3, nkx2.7, pparab, ptpn11a, rarga, rb1, smad1, smad3a, tek, vegfaa","ALTERED LARVAL DEVELOPMENT; IMPAIRED DEVELOPMENT"
"GO:0048856","4","50.1315325793118","0.0626108497684931","33.33","igf1rb, nr2f5, rxraa, rxrbb","ALTERED NEUROANATOMY"
"GO:0009790","21","50.9360228712378","0.0399680379357054","12.43","acvrl1, dad1, dldh, e2f7, flt1, gli1, hoxb1a, hsd17b2, hsf1, mapk3, nkx2.7, nup133, pax6b, rarga, rdh10a, rnf2, rxraa, smad1, smad3a, tcf7, wls","DEFECT OF EMBRYOGENESIS"
"CONSTITUTIVE ANDROSTANE RECEPTOR PATHWAY","4","51.0693068808015","0.148561516876952","13.33","alas1, hsp90aa1.2, ncoa2, rxraa","SUPPRESSION CONSTITUTIVE ANDROSTANE RECEPTOR NR1L3; ACTIVATION CONSTITUTIVE ANDROSTANE RECEPTOR"
"GO:0048870","23","54.9449188757988","0.04621830709499","11.5","acvrl1, cd40, cdc42, drd1b, drd2b, epha2a, f3a, flt1, hmox1a, id1, ikbkap, jun, ldha, lyn, mapk3, P2RY1, pax6b, ptpn11a, rras, sele, smad3a, syk, tek","INCREASED MOTILITY"
"GO:0050673","12","55.0923305904598","0.111059258898218","14.63","acvrl1, cdc42, f3a, flt1, gli1, hmox1a, id1, jun, pax6b, rb1, smad3a, tek","INCREASE REGENERATIVE CELL PROLIFERATION TUBULAR EPITHELIAL CELLS; INCREASE REGENERATIVE CELL PROLIFERATION TERMINAL BRONCHIOLAR EPITHELIAL CELLS"
"GO:0007568","11","55.4324445753289","0.115879038410219","12.79","arntl1a, chek1, dldh, h2afx, igfbp2a, jun, mapk3, P2RY1, rad54l, rbl1, SERP1","ACCELERATED AGING"
"GO:0044703","20","55.4339516435721","0.0516894906932561","17.24","arntl1a, cad, dldh, drd1b, gamt, gli1, glra1, h2afx, hsd11b2, hsf1, igfbp2a, mapk3, ndc1, P2RY1, pde5ab, rnf2, rxraa, sirt2, txn, umps","N/A REPRODUCTIVE FAILURE"
"UPPER MOTOR NEURON DYSFUNCTION","22","57.2846738561187","0.0365784849313743","4.64","bckdha, ddb2, dhcr7, dldh, dnm1l, eif2b4, gabra5, gamt, glra1, gria4a, hnrnpa1b, mre11a, ndufa6, ndufs8a, nup133, pax6b, pccb, pola1, pqbp1, rbm28, stub1, tars","DECREASE HISTAMINERGIC NEURON EXCITATION; OCCURRENCE CYTOPLASMIC VACUOLIZATION BILE DUCT CELL; OCCURRENCE CYTOPLASMIC VACUOLIZATION KUPFFER CELL"
"REGULATION OF CELL DEATH","29","57.6014094221649","0.0342715437612024","10.82","atf6, cd40, cdc42, dad1, dnm1l, gabra5, gnrh3, gsk3b, hdac3, hmox1a, hsf1, hsp90aa1.2, id1, jun, ldha, mre11a, nkx2.7, pparab, psmd10, rarga, rb1, sirt2, slc25a5, smad3a, syk, tek, txn, vegfaa, ywhaz","N/A CELL INJURY/DEATH"
"GO:0005488","149","58.0697522780319","0.00649226072837794","13.85","acvrl1, ahr1b, ahr2, alas1, anxa2a, arntl1a, atf6, bmp2b, cad, cd40, cdc42, cdc45, cfl1l, chek1, cnot4b, cpsf5, csnk2a2a, cwc15, cyp2aa3, cyp2p10, cyp2v1, cyp51, dao.1, ddb2, dhcr7, dldh, dnm1l, e2f7, eci2, eif2b4, eif3ha, eif3ja, eif3s10, epha2a, esrra, esrrga, exosc2, fabp3, farsa, farsb, fasn, flt1, foxo1a, foxo3a, gad2, gcat, gli1, glra1, gnrh3, gsk3b, gtf2b, h2afx, hat1, hdac3, hif1aa, hmox1a, hnrnpa1b, hoxb1a, hsf1, hsp90aa1.1, hsp90aa1.2, id1, igf1rb, igfbp2a, ikbkap, imp4, jun, kdelr2b, lig3, lsm1, lyn, mapk3, mcm4, mmp30, mre11a, myl6, ncbp2, ncoa2, ndufs8a, nfia, nhp2, nkx2.7, npffr1l2, nr2f5, nrf1, pax6b, pck2, pde5ab, pola1, pola2, polr1e, polr2j, polr3d, pom121, pparab, pqbp1, prpf4, ptpn11a, ptpn4a, pvalb2, rab5c, rad21a, rad54l, ran, rap1b, rarga, rb1, rbl1, rbm28, rnf2, rpa1, rpa3, rpl15, rpl19, rpl24, rps6ka5, rps9, rras, rxraa, rxrbb, sae1, sar1b, sele, sf3a3, sfrp1b, sirt2, smad1, smad3a, snrpb, snrpc, sox19b, srsf10b, stub1, syk, ta, tars, tcf7, tek, timp2b, tkta, tpm4a, tra2a, ube2ia, uqcrc1, uqcrc2b, vegfaa, vldlr, wls, zgc-86598","INCREASED BINDING OF CHEMICALS TO 2U SERUM"
"LIVER X RECEPTOR PATHWAY","2","58.4651669977892","0.265331187851366","16.67","fasn, rxraa","ACTIVATION LXR; ACTIVATION LXR ALPHA"
"INCREASED SUSCEPTIBILITY TO FRACTURES","5","58.835309038269","0.123881516500782","14.29","hnrnpa1b, ikbkap, kdelr2b, nhp2, rb1","INCREASED DISEASE SUSCEPTIBILITY"
"GO:0005216","7","59.7385940097929","0.0991674024500694","29.17","chrna6, gabra5, glra1, gria3a, gria4a, gria4b, kcnh2a","IMPAIRED ION CHANNELS"
"ABNORMAL RESPIRATORY SYSTEM MORPHOLOGY","23","60.7933076233152","0.0449527570398758","15.65","acvrl1, cdc42, cdc45, chrm3a, dhcr7, farsa, farsb, gli1, hnrnpa1b, ikbkap, mcm4, nhp2, pax6b, pmm2, pola1, ptpn11a, rarga, rb1, rras, smad3a, snrpb, tars, umps","INCREASED RESPIRATORY DISTRESS/ARREST"
"GO:0006629","33","61.0104805806298","0.0259371200378551","16.02","alas1, alg6, cdc42, crls1, cyp51, dhcr7, dldh, eci2, fabp3, fasn, flt1, hdac3, hsd11b2, hsd17b2, hsd3b1, lyn, mapk3, ncoa2, pccb, pck2, pigx, pparab, ptpn11a, ran, rb1, rbl1, rdh10a, rxraa, sirt2, stub1, tek, vldlr, zgc-86598","ALTERATION LIPID METABOLISM"
"GO:0040011","26","63.2162856683785","0.0389208940911527","11.45","acvrl1, cd40, cdc42, drd1b, drd2b, epha2a, f3a, flt1, hmox1a, id1, ikbkap, jun, ldha, lyn, mapk3, P2RY1, pax6b, ptpn11a, rpl24, rps6ka5, rras, sele, smad3a, syk, tek, vldlr","INCREASED LOCOMOTION; INCREASED MUSCULAR WAVES IN FOOT; DECREASED LOCOMOTION"
"BILE ACID AND BILE SALT TRANSPORT","2","64.4861099723518","0.295432005843739","40","ncoa2, rxraa","INHIBITION BILE SALT EXPORT PUMP ABCB11"
"CTOME BILE ACID AND BILE SALT METABOLISM","2","64.4861099723518","0.295432005843739","40","ncoa2, rxraa","BILE ACCUMULATION PATHOLOGICAL CONDITION"
"GO:0042446","4","64.6192850406999","0.167030378145636","14.29","dhcr7, hsd11b2, hsd17b2, hsd3b1","INCREASE LUTEINIZING HORMONE LH; REPRESSED EXPRESSION OF STEROIDOGENIC ENZYMES"
"NUCLEAR RECEPTORS","5","65.7683413252012","0.0674499494815675","9.62","esrra, pparab, rarga, rxraa, rxrbb","ACTIVATION HEPATIC NUCLEAR RECEPTORS"
"GO:0004872","31","67.0428746028271","0.0284037778177858","12.97","acvrl1, bmp2b, chrm3a, chrna6, drd1b, drd2b, ednrab, epha2a, esrra, esrrga, f3a, flt1, gabbr1b, gabra5, glra1, gnrh3, gria1b, gria3a, gria4a, gria4b, igf1rb, npffr1l2, nr2f5, P2RY1, paqr3a, pparab, rarga, rxraa, rxrbb, tek, vegfaa","ACTIVATION PXR/SXR"
"GO:0005515","12","67.7652550063004","0.0463663178513383","25.53","arntl1a, cdc42, e2f7, gli1, hsp90aa1.1, hsp90aa1.2, ptpn11a, rab5c, ran, smad3a, ta, vegfaa","BINDING SH-/SELEN-PROTEINS; COVALENT BINDING PROTEIN"
"ABNORMAL LUNG MORPHOLOGY","22","68.1207144678205","0.046820913023428","17.19","acvrl1, cdc42, cdc45, chrm3a, dhcr7, farsa, farsb, gli1, ikbkap, mcm4, nhp2, pax6b, pmm2, pola1, ptpn11a, rarga, rb1, rras, smad3a, snrpb, tars, umps","INCREASE ADENOMAS/CARCINOMAS BRONCHIOLOALVEOLAR"
"GO:0007268","4","68.1394415881034","0.214831248847976","11.43","chrm3a, chrna6, gabra5, glra1","REDUCTION NEURONAL SYNAPTIC INHIBITION"
"LIPID ACCUMULATION IN HEPATOCYTES","7","69.3739179861356","0.076707976687401","21.88","farsa, farsb, hnrnpa1b, pck2, pmm2, sar1b, tars","INCREASE PRENEOPLASTIC FOCI HEPATOCYTES"
"GO:0042060","14","70.0376749525805","0.0472580025768941","15.91","acvrl1, anxa2a, cd40, cdc42, f3a, hmox1a, lyn, mapk3, P2RY1, pparab, ptpn11a, smad3a, syk, ywhaz","FAILURE IN VASCULAR REPAIR MECHANISMS UNRESOLVED BLOOD LOSS HEMORRHAGE"
"GO:0001508","3","70.4455727862843","0.226823156499309","20","drd1b, glra1, kcnh2a","ALTERED ACTION POTENTIAL"
"GO:0001816","15","70.552899903902","0.0426168959929445","12.5","cd40, drd2b, hmox1a, hsf1, lyn, mapk3, mre11a, polr3d, polr3f, pqbp1, ptpn11a, rps6ka5, seh1l, smad3a, syk","NON-NEURONAL PRODUCTION OF TNF EPITHELIAL IRRITATION; PRODUCTION OF NERVE GROWTH FACTOR  EPITHELIAL IRRITATION; NON-NEURONAL PRODUCTION OF IL-8/CXCL1 EPITHELIAL IRRITATION"
"ABNORMAL NASAL MORPHOLOGY","20","70.8062441545111","0.0397011906853545","12.9","ahr1b, cdc42, dhcr7, exosc2, gnrh3, hoxb1a, nfia, nkx2.7, pmm2, pqbp1, prpf4, ptpn11a, rarga, rb1, rpl15, rpl31, rpl35a, rps24, snrpb, umps","INCREASE SITE OF CONTACT NASAL TUMORS"
"ABNORMALITY OF BLOOD AND BLOOD FORMING TISSUES","29","71.5544793359019","0.0319366200137494","7.18","acvrl1, alg6, cad, cd40, cdc42, dldh, dnm1l, farsa, farsb, flt1, gli1, hmox1a, mcm4, ndufs8a, nhp2, pccb, pmm2, ptpn11a, rb1, rpl15, rpl31, rpl35a, rps24, rras, sar1b, smad3a, tars, tek, umps","DAMAGING RED BLOOD CELLS; HEMOLYSIS"
"DECREASED BODY WEIGHT","31","72.0333468951802","0.0289712634710386","13.72","cdc45, chrm3a, ddb2, dhcr7, dldh, dnm1l, farsb, flt1, gabra5, gli1, gnrh3, gria4a, hsd11b2, ndufa11, ndufa6, ndufs8a, pccb, pmm2, pola1, pqbp1, ptpn11a, rarga, rb1, rpl15, rpl31, rpl35a, rps24, sar1b, snrpb, stt3a, umps","DECREASED BODY WEIGHT"
"ARYL HYDROCARBON RECEPTOR PATHWAY","3","72.2575290750103","0.239743619110218","6.25","ahr1b, hsp90aa1.2, jun","UP REGULATION CYP1A1; ACTIVATION AHR"
"ABNORMALITY OF ADRENAL PHYSIOLOGY","6","72.4790409670191","0.0912040458158541","6.52","hsd11b2, hsd3b1, mcm4, rbm28, snrpb, sox19b","INCREASE RENAL PATHOLOGY DUE TO VTG DEPOSITION; DECREASED RENAL ABILITY TO DILUTE URINE; OCCURRENCE KIDNEY TOXICITY; INCREASED KIDNEY FAILURE"
"GO:0050663","4","72.8036719297926","0.201162388600361","13.33","drd2b, lyn, mapk3, syk","RELEASE CYTOKINE"
"STEROID HORMONE MEDIATED SIGNALING PATHWAY","5","72.8817765186173","0.0747512887395291","4.9","esrra, esrrga, pparab, rxraa, rxrbb","DECREASE STEROIDOGENIC ACUTE REGULATORY PROTEIN STAR; DECREASED HSD17B10 EXPRESSION; REDUCED MATURATION INDUCING STEROID PLASMA"
"TRIGLYCERIDE METABOLIC PROCESS","3","73.3037781018444","0.0740595429100877","18.75","fabp3, pck2, ptpn11a","ACCUMULATION TRIGLYCERIDE"
"ABNORMALITY OF THE ABDOMINAL ORGANS","27","73.6883426772627","0.02504201249829","15.98","acvrl1, bckdha, dhcr7, dldh, farsa, farsb, flt1, hmox1a, hnrnpa1b, ikbkap, mcm4, mre11a, ndufa11, ndufa6, ndufs8a, nhp2, pccb, pck2, pmm2, ptpn11a, rarga, rras, sar1b, stub1, tars, tkta, umps","IMPAIRED DEVELOPMENT OF REPRODUCTIVE ORGANS"
"CTOME SIGNALING BY EGFR","2","73.6905435163405","0.111972856215223","25","cdc42, ptpn11a","ACTIVATION EGFR"
"GO:0007269","8","74.0552790232889","0.070234359638155","32","chrna6, dnm1l, drd1b, drd2b, gad2, gsk3b, P2RY1, rap1b","OVERACTIVATION NEURONOTRANSMITTER RELEASE"
"MORTALITY AGING","3","74.3311320441366","0.0341994099691767","11.54","dnm1l, pqbp1, snrpb","REDUCED FITNESS OR EVEN MORTALITY ACIDOSIS HYPOVOLEMIC SHOCK AND ORGAN DYSFUNCTION; INCREASE MORTALITY; INCREASED MORTALITY"
"GO:0003707","6","75.7033435337412","0.0561218499280105","18.75","esrra, esrrga, pparab, rarga, rxraa, rxrbb","REDUCED MATURATION INDUCING STEROID RECEPTOR SIGNALLING OOCYTE"
"ABNORMALITY OF THE MITOCHONDRION","6","78.597996253009","0.0339686232630338","4.76","atp5e, dldh, dnm1l, ndufa11, ndufa6, ndufs8a","INJURY MITOCHONDRIA; DAMAGING MITOCHONDRIA; N/A MITOCHONDRIAL DYSFUNCTION 1"
"GO:0046903","27","78.7059990522826","0.0220213728485521","11.69","anxa2a, arntl1a, cad, cd40, chrm3a, chrna6, cyp51, dnm1l, drd1b, drd2b, gad2, gsk3b, hmox1a, hsp90aa1.2, lyn, mapk3, P2RY1, pdia4, psmd6, ptpn11a, rab5c, rap1b, SERP1, slc25a5, syk, umps, wls","SUPPRESSION VLDL SECRETION; INCREASE MUCIN PRODUCTION; INCREASED SECRETION OF LOCAL GROWTH FACTORS"
"POSITIVE REGULATION OF GENE EXPRESSION","24","80.2017958563598","0.0236717523051998","13.26","cd40, chek1, drd1b, f3a, gsk3b, hmox1a, hsp90aa1.2, id1, mapk3, mre11a, pax6b, polr1e, polr3d, polr3f, pqbp1, ptpn11a, rps9, smad1, smad3a, sox19b, syk, tra2a, vegfaa, znrd1","ALTERED GENE EXPRESSION"
"GO:0006120","4","80.6900970096568","0.0653694554913881","14.81","dldh, ndufa11, ndufa6, ndufs8a","BINDING OF INHIBITOR NADH-UBIQUINONE OXIDOREDUCTASE COMPLEX I"
"PYRUVATE METABOLIC PROCESS","10","82.2571236377494","0.0564434658762875","17.86","dldh, ldha, ndc1, nup133, nup37, pck2, pom121, pparab, sec13, seh1l","INHIBITION 4-HYDROXYPHENYL-PYRUVATE DIOXYGENASE HPPD ENZYME"
"ABNORMAL SOCIAL BEHAVIOR","6","82.5060128860285","0.0343432601668652","23.08","ndufa11, ndufa6, ndufs8a, pola1, snrpb, tars","ABNORMAL FORAGING ACTIVITY AND BEHAVIOR"
"RESPONSE TO REACTIVE OXYGEN SPECIES","6","82.7201228082583","0.112084761411859","10.71","hmox1a, hsf1, jun, ldha, mapk3, txn","INCREASED REACTIVE OXYGEN SPECIES"
"GO:0006839","8","83.9579264495669","0.0484991629985251","17.39","atp5e, COX5B_2of3, gsk3b, hsp90aa1.2, sae1, slc25a5, uqcrc2b, ywhaz","REDUCTION CHOLESTEROL TRANSPORT IN MITOCHONDRIA"
"JNK CASCADE","3","84.0494643082304","0.107192304830138","13.64","cdc42, hdac3, syk","ACTIVATION JNK"
"PEPTIDYL LYSINE MODIFICATION","13","84.7823111649897","0.0421969299573878","18.31","chek1, gtf2b, hat1, mapk3, ndc1, nup133, nup37, pom121, rps6ka5, sae1, seh1l, sirt2, ube2ia","N/A COVALENT BINDING TO PROTEIN POSSIBLY LYSINE RESIDUE"
"SQUAMOUS CELL CARCINOMA","2","85.0498861196634","0.0104533571406849","20","ddb2, tars","INCREASE PAPILLOMAS/CARCINOMAS SQUAMOUS CELLS; INCREASE RESPIRATORY OR SQUAMOUS METAPLASIA; SQUAMOUS METAPLASIA ABERRANT BASAL CELLS"
"GO:0006898","7","87.0279521307908","0.0677576691672997","18.42","anxa2a, drd2b, gria1b, hsp90aa1.2, sele, syk, vldlr","REDUCTION VITELLOGENIN ACCUMULATION INTO OOCYTES AND OOCYTE GROWTH/DEVELOPMENT; INCREASED LDL UPTAKE"
"GO:0009611","18","87.4371503558529","0.0337555921171958","16.07","acvrl1, anxa2a, cd40, cdc42, drd2b, f3a, gli1, hmox1a, jun, lyn, mapk3, P2RY1, pax6b, pparab, ptpn11a, smad3a, syk, ywhaz","ACCUMULATION DAMAGED MITOCHONDRIAL DNA"
"GO:0048813","6","90.4046448767865","0.0386660146726343","46.15","cdc42, dnm1l, gsk3b, id1, pqbp1, vldlr","ABERRANT DENDRITIC MORPHOLOGY"
"GO:0045333","8","92.6799778899832","0.0244330843677316","11.11","COX5B_2of3, cox7c, dldh, ndufa11, ndufa6, ndufs8a, uqcrc1, uqcrc2b","INCREASE OXIDATIVE METABOLISM"
"ELECTRON TRANSPORT CHAIN","8","92.6799778899832","0.0244330843677316","11.76","COX5B_2of3, cox7c, dldh, ndufa11, ndufa6, ndufs8a, uqcrc1, uqcrc2b","DISRUPTION MITOCHONDRIAL ELECTRON TRANSPORT CHAIN"
"GO:0005102","20","92.9084606805569","0.0195733730206297","9.62","arntl1a, cdc42, chgb, drd2b, eif3s10, gabra5, gtf2b, igfbp2a, lyn, ncoa2, P2RY1, ptpn11a, ran, rarga, rb1, rxraa, smad3a, stub1, syk, wls","DECREASED TESTOSTERONE BINDING TO ANDROGEN RECEPTOR HYPOTHALAMUS"
"CTOME ACTIVATION OF GENE EXPRESSION BY SREBF SREBP","6","94.3314972733497","0.0548980000236072","50","cyp51, dhcr7, fasn, ncoa2, pparab, rxraa","UP REGULATION SREBF2"
"ABNORMALITY OF THE LIVER","21","94.7002782899183","0.0165118494959854","2.8","acvrl1, dhcr7, dldh, farsa, farsb, flt1, hmox1a, hnrnpa1b, mcm4, ndufa11, ndufa6, ndufs8a, nhp2, pccb, pck2, pmm2, ptpn11a, rras, sar1b, tars, tkta","INCREASED INDUCTION OF UDPGT'S IN LIVER; INCREASED LIVER STEATOSIS; INCREASED LIVER STEATOSIS; N/A HEPATOTOXICITY HEPATOPATHY INCLUDING A CONSTELLATION OF OBSERVABLE EFFECTS; INDUCTION SUSTAINED HEPATOTOXICITY"
"ABNORMAL LIVER MORPHOLOGY","20","95.0190511975309","0.0177845311792014","16.81","acvrl1, dldh, farsa, farsb, flt1, hmox1a, hnrnpa1b, mcm4, ndufa11, ndufa6, ndufs8a, nhp2, pccb, pck2, pmm2, ptpn11a, rras, sar1b, tars, tkta","INDUCTION LIVER “DYSFUNCTIONAL” CHANGES BY CGA 330050; INFLAMMATION LIVER; N/A LIVER FIBROSIS; INCREASE RBC CONGESTION IN LIVER; INCREASE LIVER AND SPLENIC HEMOSIDEROSIS; REDUCTION VITELLOGENIN SYNTHESIS IN LIVER; INCREASE VITELLOGENIN SYNTHESIS IN LIVER; FORMATION LIVER FIBROSIS; FORMATION LIVER TUMOR"
"GO:0046983","29","97.135025692125","0.0117720162028827","14.72","ahr1b, arntl1a, atf6, cpsf5, dnm1l, drd2b, fasn, gad2, h2afx, hmox1a, hsf1, hsp90aa1.2, id1, jun, kcnh2a, ncoa2, nrf1, P2RY1, pola2, polr2j, ran, rxraa, sae1, smad3a, snrpc, stub1, tars, tkta, tpm4a","DIMERIZATION AHR/ARNT; REDUCED DIMERIZATION ARNT/HIF1-ALPHA"
"GO:0099536","13","99.9135559825115","0.0358886202439844","11.71","chrm3a, chrna6, dnm1l, drd1b, drd2b, gabra5, gad2, glra1, gria1b, gria4a, gsk3b, P2RY1, rap1b","DECREASED NEURONAL NETWORK FUNCTION IN ADULT BRAIN; DECREASED NEURONAL NETWORK FUNCTION IN ADULT BRAIN"
"ABNORMAL CIRCULATING ESTROGEN LEVEL","2","99.97928055872","0.201627239955707","14.29","gnrh3, sox19b","INCREASED CIRCULATING ESTROGEN LEVELS"
"GO:0030163","15","103.799685792479","0.0217481563294348","9.8","anxa2a, arntl1a, cnot4b, cyp51, gsk3b, hsp90aa1.2, psmd10, psmd6, sirt2, smad3a, stub1, tceb1b, ube2ia, vldlr, zgc-86598","INCREASED CATABOLISM OF MUSCLE PROTEIN"
"DECREASED FERTILITY","7","104.847231534012","0.0362758960471196","9.21","chrm3a, gnrh3, hsd3b1, ptpn11a, snrpb, sox19b, stub1","IMPAIRED FERTILITY; DECREASED SPERM QUANTITY OR QUALITY IN THE ADULT DECREASED FERTILITY; REDUCTION CUMULATIVE FECUNDITY AND SPAWNING; DECREASED SPERM QUANTITY OR QUALITY IN THE ADULT DECREASED FERTILITY; DECREASED SPERM QUANTITY OR QUALITY IN THE ADULT DECREASED FERTILITY; DECREASED TESTOSTERONE"
"GO:0046562","3","108.494659466156","0.0721158330778803","11.11","dldh, ldha, pck2","DECREASED GLUCOSE OXIDASE ENZYME ACTIVITY"
"ABNORMAL FORM OF THE VERTEBRAL BODIES","3","109.364127544455","0.0709146496866178","9.09","dhcr7, kdelr2b, pmm2","CLONAL EXPANSION/CELL PROLIFERATION TO FORM ALTERED HEPATIC FOCI AHF"
"RENAL TUBULAR DYSFUNCTION","5","109.847036896481","0.0565976241298752","19.23","cad, ndufa11, ndufa6, ndufs8a, pmm2","INCREASE HYPERPLASIA RENAL TUBULAR CELLS; INCREASE CYTOTOXICITY RENAL TUBULAR CELL; INCREASE ADENOMAS/CARCINOMAS RENAL TUBULAR; OCCURRENCE RENAL PROXIMAL TUBULAR NECROSIS"
"GO:0003824","9","111.535497732157","0.0265697239140617","13.85","alas1, eci2, gad2, gcat, ldha, tkta, umps, uqcrc1, uqcrc2b","DECREASED DHB4/HSD17B4; DECREASE INCORPORATION OF ACTIVE IODIDE INTO IODOTYROSINES; INHIBITION PROLYL HYDROXYLASES; INHIBITION UROD; DECREASE AKT/ENOS ACTIVITY; INHIBITION DEIODINASE 2; INHIBITION DEIODINASE 1; INHIBITION IODOTYROSINE DEIODINASE IYD; INHIBITION DEIODINASE 3; INHIBITION DUAL OXIDASE; INDUCTION UPREGULATION OF GLUCURONYLTRANSFERASE ACTIVITY"
"GO:0007059","11","112.377176176915","0.017857792665522","25","cdc42, mre11a, ndc1, nup37, ran, rb1, seh1l, sirt2, slc25a5, ube2ia, zgc-86598","INCREASED CHROMOSOME MISSEGGREGATION"
"GO:0004882","5","114.171538036236","0.0474442208521004","14.29","jun, ncoa2, ran, rb1, stub1","N/A ANDROGEN RECEPTOR ANTAGONISM; AGONISM ANDROGEN RECEPTOR; DECREASED ANDROGEN RECEPTOR ACTIVITY; ACTIVATION ANDROGEN RECEPTOR"
"ABNORMALITY OF THE PITUITARY GLAND","7","115.461060565291","0.0331315982293411","14.58","farsa, hsd3b1, pmm2, pola1, rbm28, snrpb, sox19b","INCREASED ADENOMAS PITUITARY"
"G TGF BETA SIGNALING PATHWAY","6","116.935231562739","0.0278970780427394","8.82","acvrl1, id1, mapk3, rbl1, smad1, smad3a","ACTIVATION TGF-BETA PATHWAY; UP REGULATION TGFBETA1 EXPRESSION"
"ABNORMALITY OF REPRODUCTIVE SYSTEM PHYSIOLOGY","18","118.104904683379","0.0115646330692168","17.48","ahr1b, chrm3a, ddb2, dnm1l, eif2b4, gnrh3, hsd3b1, mre11a, pmm2, pola1, prpf4, ptpn11a, rbm28, rras, snrpb, sox19b, stub1, tkta","N/A IMPAIRMENT OF REPRODUCTIVE CAPACITY"
"ENDOMETRIAL CANCER","4","118.444678494968","0.0406312125940307","5.88","ddb2, gsk3b, mapk3, tcf7","INCREASE ENDOMETRIAL ADENOCARCINOMAS"
"GO:0016055","4","118.48667397128","0.036892551462821","17.39","sfrp1b, ta, tcf7, wls","ALTERATION WNT PATHWAY"
"G VEGF SIGNALING PATHWAY","3","119.319010923892","0.106906874816453","14.29","cdc42, mapk3, vegfaa","REDUCED PRODUCTION VEGF"
"GO:0048469","3","123.292157100204","0.0715817449491999","12.5","dldh, rb1, sirt2","INCREASED OOCYTE MATURATION"
"DNA DAMAGE RESPONSE","5","124.761630128689","0.0280470846632685","8.62","chek1, ddb2, h2afx, mre11a, rb1","INCREASED DNA DAMAGE-REPAIR"
"ABNORMAL CORNEAL EPITHELIUM MORPHOLOGY","4","125.079402390495","0.0484704585676065","30.77","ddb2, ikbkap, pax6b, tars","INCREASED ACCUMULATION OF ALPHA2U MICROGLOBULIN PROXIMAL TUBULAR EPITHELIUM"
"BREAST CANCER PATHWAY","7","125.20432360219","0.0200886974701037","6.14","ddb2, gsk3b, jun, mapk3, mre11a, rb1, tcf7","N/A BREAST CANCER"
"ELEVATED RED CELL ADENOSINE DEAMINASE LEVEL","4","125.311552702554","0.0667616328415509","22.22","rpl15, rpl31, rpl35a, rps24","INCREASED CYCLIC ADENOSINE MONOPHOSPHATE"
"PURE RED CELL APLASIA","4","125.311552702554","0.0667616328415509","20","rpl15, rpl31, rpl35a, rps24","N/A METHEMOGLOBINEMIA DECREASED HEMOGLOBIN HEMATOCRIT RED BLOOD CELL NUMBER"
"GO:0006412","13","125.978500966718","0.0157057464134242","12.04","eif2b4, eif3ha, eif3ja, eif3s10, farsa, rad21a, rpl15, rpl19, rpl24, rpl31, rpl35a, rps24, rps9","ALTERED PROTEIN PRODUCTION"
"HYPERACTIVITY","7","128.97672221567","0.0270354067352925","14","dhcr7, gabra5, gamt, gria4a, pola1, snrpb, tkta","INDUCTION ATAXIA PARALYSIS OR HYPERACTIVITY; INCREASED ATAXIA PARALYSIS OR HYPERACTIVITY; N/A ATAXIA PARALYSIS OR HYPERACTIVITY"
"GO:0003158","5","130.005336594871","0.0275788585178809","20.83","acvrl1, anxa2a, fasn, id1, rap1b","IMPAIRMENT ENDOTHELIAL NETWORK"
"REGULATION OF PROTEOLYSIS","10","130.118972902242","0.0201071808107125","8.93","anxa2a, f3a, gsk3b, hsf1, psmd10, sirt2, smad3a, stub1, syk, vegfaa","IMPAIRED PROTEOSTASIS"
"GO:0015908","4","130.790716897153","0.0841868182736322","18.18","drd2b, fabp3, pparab, syk","INCREASED FA INFLUX"
"GO:0004970","2","133.482163864363","0.0757942135440972","33.33","gria1b, gria4a","BINDING OF AGONIST IONOTROPIC GLUTAMATE RECEPTORS"
"ABNORMAL CIRCULATING CHOLESTEROL CONCENTRATION","3","138.151183445972","0.057764061333344","27.27","dhcr7, pmm2, sar1b","DECREASED CHOLESTEROL; PERTURBATION OF CHOLESTEROL"
"NCRNAS INVOLVED IN WNT SIGNALING IN HEPATOCELLULAR CARCINOMA","3","138.7798987231","0.0559553066429999","6.25","gsk3b, jun, tcf7","INCREASE HERITABLE MUTATIONS IN OFFSPRING"
"ABNORMALITY OF THE OVARY","9","140.18321115061","0.0216525608966449","15.79","eif2b4, flt1, gnrh3, hsd3b1, mre11a, pax6b, pmm2, ptpn11a, sox19b","REDUCED PROSTAGLANDINS OVARY"
"GO:0050805","4","143.506294888117","0.0271701022113662","23.53","drd1b, drd2b, gria1b, rap1b","INCREASED NEURONAL SYNAPTIC INHIBITION"
"ABNORMAL OVARIAN MORPHOLOGY","7","144.199733604055","0.0309823283261171","18.92","flt1, gnrh3, hsd3b1, pax6b, pmm2, ptpn11a, sox19b","PROMOTION OVARIAN GRANULAR CELL TUMORS; DECREASED OVARIAN E2; PROMOTION OVARIAN ADENOMAS"
"SIGNALING OF HEPATOCYTE GROWTH FACTOR RECEPTOR","4","145.750334968116","0.0267697695417218","11.76","jun, mapk3, ptpn11a, rap1b","OCCURRENCE CYTOPLASMIC VACUOLIZATION HEPATOCYTE; OCCURRENCE BALLOONING DEGENERATION HEPATOCYTE"
"GO:0019882","4","148.240187602502","0.0356314142357087","6.78","psmd10, psmd6, sar1b, sec13","GENERATION OF NOVEL EPITOPES  ANTIGEN PRESENTATION"
"CYTOPLASMIC RIBOSOMAL PROTEINS","8","150.033069057648","0.0243870041615945","5.56","rpl15, rpl19, rpl24, rpl31, rpl35a, rps24, rps25, rps9","OCCURRENCE CYTOPLASMIC VACUOLIZATION PODOCYTE"
"REGULATION OF WNT SIGNALING PATHWAY","7","150.685965833114","0.0195827152719723","8.86","gli1, gsk3b, igfbp2a, psmd10, psmd6, smad3a, wls","INHIBITION WNT PATHWAY"
"CTOME CELLULAR RESPONSE TO HYPOXIA","4","152.506397852479","0.0464881552992703","9.3","psmd10, psmd6, tceb1b, vegfaa","N/A HYPOXIA"
"HUMAN THYROID STIMULATING HORMONE TSH SIGNALING PATHWAY","4","152.772934161086","0.0187488547501171","3.7","jun, mapk3, rap1b, rb1","DECREASED TRIIODOTHYRONINE T3 IN SERUM; INCREASE THYROID-STIMULATING HORMONE TSH; DECREASED THYROXINE T4 IN SERUM; INCREASED THYROID-STIMULATING HORMONE TSH"
"GO:0045444","3","153.039175695218","0.0459728109041288","7.32","arntl1a, sirt2, smad3a","INCREASED ADIPOGENESIS"
"LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS","2","155.926830430945","0.0560620592841055","33.33","anxa2a, vldlr","UP REGULATION LDLR LOW DENSITY LIPOPROTEIN RECEPTOR"
"CTOME METABOLISM OF PORPHYRINS","2","157.693953382849","0.00884551141922754","66.67","alas1, hmox1a","ACCUMULATION HIGHLY CARBOXYLATED PORPHYRINS"
"GO:0004620","2","161.734746626611","0.00107561602516647","40","chrm3a, hmox1a","INHIBITION PHOSPHOLIPASE A"
"GO:0060291","3","168.191639376793","0.0146843381331327","21.43","drd1b, drd2b, gsk3b","DECREASED LONG-TERM POTENTIATION LTP"
"BLADDER CANCER","3","170.509367189735","0.0359058675194149","7.14","rb1, rps6ka5, vegfaa","INCREASE CANCER"
"GO:0006703","2","170.637354742944","0.0313168882594237","40","hsd17b2, hsd3b1","REDUCTION 17BETA-ESTRADIOL SYNTHESIS BY OVARIAN GRANULOSA CELLS"
"LOCOMOTORY BEHAVIOR","3","172.064744778195","0.0148491194597787","4.84","drd1b, glra1, ncoa2","REDUCED SWIMMING SPEED; REDUCED SWIMMING PERFORMANCE"
"GO:0001963","2","172.257630867596","0.028441205403538","16.67","drd1b, drd2b","INCREASE DOPAMINERGIC ACTIVITY; DECREASED DOPAMINERGIC ACTIVITY"
"GO:0009058","2","173.266649620924","0.0377661339816366","28.57","alas1, gcat","INCREASED TRIGLYCERIDE FORMATION; INCREASED TRIGLYCERIDE FORMATION; DECREASE TETRAHYDROBIOPTERIN; ROS FORMATION"
"GO:0019226","2","173.741184267536","0.0310746885433783","16.67","drd1b, glra1","REDUCTION ECDYSIS MOTONEURON BURSTS"
"GO:0007588","2","175.13076541866","0.0233613673278973","14.29","drd2b, hmox1a","INCREASE BILIARY EXCRETION TH GLUCURONIDE"
"REGULATION OF PH","2","176.217333877334","0.0170147829005246","14.29","atp6v1h, mapk3","DECREASE INTRACELLULAR PH"
"GO:0007612","4","181.848879443245","0.0110041629470621","16.67","drd1b, drd2b, gabra5, jun","IMPAIRMENT LEARNING AND MEMORY"
"ABNORMAL BLOOD SODIUM CONCENTRATION","2","184.984233302894","0.00652529745930505","22.22","hsd3b1, ikbkap","DECREASED SODIUM CONDUCTANCE 2; DECREASED SODIUM REABSORPTION"
"GO:0005254","2","195.10584700007","0.00454051736387965","22.22","gabra5, glra1","ACTIVATION GLUTAMATE-GATED CHLORIDE CHANNEL; ACTIVATION GLUTAMATE-GATED CHLORIDE CHANNELS"
"GO:1902476","2","195.10584700007","0.00454051736387965","33.33","gabra5, glra1","INCREASED CHLORIDE CONDUCTANCE"
